A carregar...
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
BACKGROUND: Inflammation might be a pathological mediator of cardiovascular events in patients with type 2 diabetes and high cardiovascular risk. METHODS: We investigated whether empagliflozin (EMPA) exerts anti-inflammatory effects that are reflected in decreased high-sensitivity C-reactive protein...
Na minha lista:
| Publicado no: | Diabetol Metab Syndr |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299593/ https://ncbi.nlm.nih.gov/pubmed/30574207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-018-0395-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|